Introduction
The evidence for the family history as an independent fifths dependent upon the magnitude of the continuous variable being measured. The relative risk was risk factor in the development of ischaemic heart disease is strong. There are over fourteen studies to calculated from the frequency of cases of confirmed ischaemic heart disease occurring in the group of date confirming the clustering of cases of heart disease within families. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] This has encouraged the search men with the highest measurement compared with that in the group with the lowest measurement. The for genetic factors to improve the prediction of risk and to target new areas for therapeutic intervention.
relative risk of the qualitative measurements, as with family history, was calculated from a comparison of Molecular genetic analysis has become a powerful and extensively-used tool, but the relative importance groups with and without a history of death from ischaemic heart disease in either parent, irrespective of genetic and environmental influences in ischaemic heart disease should be kept in perspective.
of age. Despite this wide definition, family history was found to have a relatively small impact on risk compared to other classical factors.
Although the relative importance of family history
Family history in ischaemic heart
would appear to be small, studies have varied enormdisease ously in their estimate of attributable risk, from 1.5 to 7. This variation has been due in part to a difference The relative importance of family history was studied in 1986 in the British Regional Heart Study,15 which in definition of 'positive family history' (parental death from heart disease, parental and sibling death under 65 was a prospective analysis of personal and environmental risk factors for ischaemic heart disease in years, etc.) and to a difference in the populations studied (age range, social mix, etc.). More importantly, males in England, Scotland and Wales. The study was based on 7735 men aged 40-59 randomly there has been difficulty in isolating inherited genetic risk from the confounding associations of classical risk selected from age-sex registers of group general practices in 24 towns and followed for 8 years. For factors that occurs in families. Two questions arise: whether the risk from a positive family history is due calculations of relative risk, men were grouped into to predict risk of death from ischaemic heart disease in the other twin. Both male and female monozygotic twins died of ischaemic heart disease at earlier ages to environmental or genetic factors; and whether the than either the dizygotic twins or the twin population genetic risk from family history is merely due to an as a whole if their respective twin had died of the aggregation of genes important to the development of same cause-up to the age of 76. The relative hazard the established factors of hypercholesterolaemia, for monozygotic male twins whose respective twins hypertension and diabetes.
had died from ischaemic heart disease when 36-65 years old was about three times that of the risk for dizygotic twins. The comparable risk for female
Genetics or environment?
monozygotic twins was just under seven times that of their dizygotic counterparts. As the age of death One of the ways in which it is possible to separate from ischaemic heart disease increased, the probabilthe influences of environment and genetics is by ity of death in the monozygotic and dizygotic twins studying the impact of adoption. In 1988, a Danish drew closer and the overall risk of death approached study was published based upon all children born that of the overall population. This would again between the years 1924 to 1926 who were subimply that genetic factors are significant in early sequently adopted by families who were biologically ischaemic death, but that the effect declines with unrelated to the adoptee.16 They studied 960 families age. The increased risks to monozygotic twins with follow-up until 1982. The aim was to compare remained significant after controlling for hypertenthe mortality rates of adoptees whose biological sion, diabetes, smoking, body-mass index, birth parents had died before the ages of 50 and 70 with cohort and education. the mortality rates of adoptees whose biological There are therefore genetic factors that relate to parents were still alive at those ages. A similar ischaemic risk which are not accounted for by comparison was made for adoptees in relation to the classical risk factors. Attempts to predict ischaemic death of their adoptive parents. Adoptees who had heart disease on the basis of known risk factors by at least one biological parent who died from any discriminant analysis correctly identifies only 39% cause before the age of 50 or 70 had mortality rates of cases.19 Whilst there are limitations to such studies, that were 1.7 and 1.8 times those of adoptees whose this would suggest that an accumulation of genes parents were both alive at those ages. The death of predisposing to classical risk factors (including choa biological parent before the age of 50 from a lesterol) within families cannot account for the total vascular cause was associated with a 4.5-fold risk accruing from a positive family history of early increase in the mortality of the adoptee from the death from ischaemic heart disease. Other factors same cause. This effect was reduced if the biological would need to be identified. The candidate gene parent survived to 70. Deaths of adoptive parents approach appeared to have been successful in the from vascular causes below the age of 50 increased determination of a new factor related to ischaemic the risk of death for the adoptees from the same heart disease in 1992. cause, but this risk was not significant.
The impact of the biological family environment on the increased risk attributed to adoptees from their early death was minimal in this study-most of
The angiotensin-converting-enzyme the participants were removed at birth to foster gene homes from their biological parents and 93% were
The potential importance of molecular medicine in then placed in their adopted home within 3 years.
defining risk and directing therapeutic intervention Whilst adoption studies cannot exclude the impact looked to be confirmed with the report of a polyof the biological family environment affecting uterine morphism in the angiotensin-converting-enzyme development of the child, as in Barker's hypothesis,17 the implication of the study is that genetic factors gene associated with the development of myocardial infarction.20 This discovery was preceeded by a Follow-up continued until 1992, when 387 participnumber of observations. Levels of angiotensinants had suffered an infarct and 865 men had converting enzyme (ACE) are known to vary enormdeveloped angina or required revascularization. ously between individuals-up to fivefold variation. 21 These 1250 case patients were then compared However, levels remain remarkably constant on with 2340 controls matched to within 1 year for age repeated measurement of any given subject. Further and smoking habit. The relative risk of ischaemic study revealed intrafamilial resemblance of angioheart disease conferred by the D allele in the whole tensin-converting-enzyme levels, leading to the disgroup was 1.08 (95% CI 0.9-1.2, p=0.16), consistcovery of a marker polymorphism consisting of the ent with no effect. Absence of significant effect was absence or presence of a 250 bp DNA fragment also found on analysis of the low-risk group as within the ACE gene.22,23 The insertion/deletion (I/D) defined by Cambien et al. polymorphism accounted for 47% of the total phenoThe Physician's Health trial investigated the effect typic variation of serum ACE. Cellular levels within of the ACE polymorphism on a smaller group of T lymphocytes correlated well with plasma levels and patients suffering myocardial infarction at an older also were related to the I/D polymorphism.24 Further age than those in the earlier study. A further prospectsegregation and linkage analysis confirmed that the I/D ive analysis concentrated on 684 cases of acute polymorphism was not itself responsible for the varimyocardial infarction consecutively collected from ation, but was in strong linkage disequilibrium with a coronary care units and compared with 537 controls controlling variant of the ACE gene, denoted Ss.25 from base populations.28 The age-and sex-matched A multicentre case-control study performed in odds ratio for myocardial infarction with DD genoFrance and Northern Ireland subsequently revealed type compared with D/I and II was 1.16 (95% CI an increased frequency of the DD genotype in 610 0.82-1.65; p=0.44). The study also examined surpatients who had suffered a myocardial infarction vival up to 22 months, which was important because under the age of 65, compared to 733 healthy earlier evidence had found that the DD genotype controls.20 The odds ratio of developing a myocardial was associated with increased left ventricular dilatainfarct holding the DD genotype (as compared with tion following anterior myocardial infarction.29 the II genotype) was calculated to be 1.34. In However, there was no difference in the cumulative addition, the data was analysed in terms of a lowmortality curves between DD and DI/II genotypes. risk group defined on the basis of a body mass index Finally, a meta-analysis has been performed on 14 below 26 kg/m2, and Apo B levels below 125 mg/dl, published studies to date, involving a total of 3171 who were not being treated for hypercholesterolaecases of acute myocardial infarction, and 5330 mia. In this group, the odds ratio for risk associated controls.30 The mean odds ratio across all studies with the DD genotype was increased to 3.2 (95% CI was 1.26 (95% CI 1.14-1.40, p<0.0001), giving an 1.7-5.9, p<0.0001). The percentage of cases of attributable risk estimate of 7% to the DD genotype. myocardial infarction associated with the DD genotype was calculated to be 8% in the total population, and 35% in the low-risk group.
The future
A flurry of activity ensued to examine the ACE Whilst it would seem that there may be an association polymorphism in many aspects of cardiology. The between the DD genotype and myocardial infarction, potential of molecular medicine appeared fulfilled allowing for the inevitable failings of any metain the identification of a new factor in the developanalysis, the impact of the polymorphism is unlikely ment of myocardial infarction which carried a signito be as significant as first reports indicated. Initial ficant risk and which could direct early therapeutic enthusiasm for the polymorphism was based on the intervention with ACE inhibitors towards a defined possibility that directed therapy with inhibitors of the population. However, evidence for the role of angiotensin-converting enzyme would selectively the ACE gene polymorphism as identified by decrease the danger of myocardial infarction in highCambien has been drawn into some doubt. risk groups. However, given the wide existing indicaThe study by Cambien et al. was a retrospective tions for ACE inhibitor use following myocardial analysis performed 3-9 months after admission to infarction,31 any trial showing selective benefit to hospital for treatment of myocardial infarction. This the DD genotype would necessarily be huge and is would have excluded the approximate 40% of probably impractical. patients who fail to survive until hospital discharge. 26 Ischaemic heart disease is multifactoral. Family The first major prospective case-control study was history and genetic factors represent only a proporcarried out by Lindpainter et al. based on the tion of the risk burden to the population. It is possible Physicians Health Study, which had recruited male, that gene-gene interactions, such as that proposed predominantly white US physicians into a trial of between the ACE polymorphism and the type 1 aspirin and beta-carotene in 1982.27 Blood samples from 14 916 subjects were used for gene analysis.
angiotensin II receptor polymorphism,32 may turn
